June 11, 2018

FDA: Hospira recalls two lots of Naloxone Hydrochloride Injection

By: Judy Mathias

Editor’s Note

The Food & Drug Administration on June 4 announced the recall by Hospira, Inc, of two lots of its opioid antagonist Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69).

The two lots, 72680LL and 76510LL, were recalled because of the potential presence of embedded and loose particulate matter on the syringe plunger.

To date, Hospira has not received reports of any adverse events associated with these lots.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat